Therapeutic Asset Ratings
130 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Olaparib
HER2-positive Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris
P2
CCC
(52)
Trastuzumab Duocarmazine
HER2-positive Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(52)
Hyaluronidase zzxf
HER2-positive Breast Cancer
Latin American Cooperative Oncology Group
P2
CCC
(51)
Trastuzumab Imbotolimod
HER2-positive Breast Cancer
Bolt Biotherapeutics, Inc.
P2
CCC
(51)
ro7771950
HER2-positive Breast Cancer
Hoffmann-La Roche
P2/3
CCC
(50)
Ganetespib
HER2-positive Breast Cancer
Memorial Sloan Kettering Cancer Center
P2
CCC
(49)
mk-2206
HER2-positive Breast Cancer
National Cancer Institute (NCI)
P2
CCC
(49)
Zn-A-1041
HER2-positive Breast Cancer
Suzhou Zanrong Pharma Limited
P1/2
CCC
(49)
9mw2821
HER2-positive Breast Cancer
Fudan University
P2
CCC
(48)
Adebelimab
HER2-positive Breast Cancer
Fudan University
P2
CCC
(48)
Aguix
HER2-positive Breast Cancer
Brigham and Women's Hospital
P2
CCC
(48)
ARX 788
HER2-positive Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Benmelstobart
HER2-positive Breast Cancer
Fudan University
P2
CCC
(48)
Catequentinib
HER2-positive Breast Cancer
Fudan University
P2
CCC
(48)
DALPICICLIB ISETIONATE
HER2-positive Breast Cancer
Sun Yat-sen University
P2
CCC
(48)
Dan-222
HER2-positive Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Datopotamab Deruxtecan
HER2-positive Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Dostarlimab
HER2-positive Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
DOTATOC
HER2-positive Breast Cancer
MedSIR
P2
CCC
(48)
Durvalumab
HER2-positive Breast Cancer
Filipa Lynce, MD
P2
CCC
(48)
Empagliflozin
HER2-positive Breast Cancer
Washington University School of Medicine
P2
CCC
(48)
Encequidar
HER2-positive Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
ERIBULIN MONOMETHANESULFONATE
HER2-positive Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P2
CCC
(48)
Famitinib
HER2-positive Breast Cancer
Fudan University
P2
CCC
(48)
Fianlimab
HER2-positive Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Showing 51 to 75 of 130 assets
Previous
Page 3 of 6
Next
